Hostname: page-component-7b7567c8c-fvjsw Total loading time: 0 Render date: 2026-11-14T12:01:03.321Z Has data issue: false hasContentIssue false
  • English
  • Français

Infection Control in Pulmonary Function Laboratories

Published online by Cambridge University Press:  02 January 2015

Ofelia C. Tablan,
Walter W. Williams and
William J. Martone
Ofelia C. Tablan*
Affiliation:
Hospital Infections Program, Center for Infectious Diseases and Office of the Director, Epidemiology Program Office, Centers for Disease Control, Public Health Service, US Department of Health and Human Services, Atlanta, Georgia
Walter W. Williams
Affiliation:
Hospital Infections Program, Center for Infectious Diseases and Office of the Director, Epidemiology Program Office, Centers for Disease Control, Public Health Service, US Department of Health and Human Services, Atlanta, Georgia
William J. Martone
Affiliation:
Hospital Infections Program, Center for Infectious Diseases and Office of the Director, Epidemiology Program Office, Centers for Disease Control, Public Health Service, US Department of Health and Human Services, Atlanta, Georgia
*
Hospital Infections Program, Center for Infectious Diseases, Centers for Disease Control, Atlanta, GA 30333
Get accessRights & Permissions [Opens in a new window]

Extract

The role of the pulmonary function (PF) laboratory and PF testing equipment in the transmission of infections has not been established. Although microorganisms have been cultured from parts of in-use pulmonary function testing equipment, a relationship between equipment contamination and transmission of infection or colonization has not been documented. Nosocomial outbreaks of respiratory infections, eg, influenza, tuberculosis, and legionellosis have been described, but transmission of the microorganisms has not been shown to be more likely in the PF laboratory or with PF testing equipment than in other areas in the hospital or with other hospital equipment. Unlike nebulizers, which have been implicated in epidemic and endemic nosocomial gram-negative bacterial infections, PF machines do not generate aerosols. PF testing equipment is thus built without provision for easy machine disassembly and disinfection, except for parts that routinely come in contact with mucous membranes or secretions (eg, mouthpieces, valves, and some tubings).

Information

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 6 , Issue 11 , November 1985, pp. 442 - 444
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1985

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

1. Gold, PM, Schwesinger, DW: Pulmonary laboratory infection control and safety, in Pulmonary Function Testing Guidelines and Controversies, ed 2. Academic Press, Inc., 1982, pp 15–19.Google Scholar
2. Hazaleus, RE, Cole, J, Berdischewsky, M: Tuberculin skin testing conversion from exposure to contaminated pulmonary function testing apparatus. Respiratory Care 1980;26:53–55.Google Scholar
3. Burton, GG, Hodgkin, JE (eds): Respiratory Care: A Guide to Clinical Practice, ed 1. Philadelphia, JB Lippincott, 1981, pp 416–455.Google Scholar
4. Renfrow, DP, Thomann, CA, Rutala, WA: Infection risks associated with spirometry, in Abstracts of the Twelfth Annual Educational Conference, Association for Practitioners in Infection Control, 1985, p 161.Google Scholar
5. Depledge, MH, Barnett, A: Aseptic techniques for lung function testing. J Hosp Infect 1981;2:369–372.Google Scholar
6. Isles, A, Maclusky, I, Corey, M, et al: Pseudomonas cepacia infection in cystic fibrosis: An emerging problem. J Pediatr 1984;104:206–210.Google Scholar
7. Hoffman, PC, Dixon, RE: Control of influenza in the hospital. Ann Intern Med 1977;87:725–728.Google Scholar
8. Van Voru, LP, Belshe, RB, Shaffer, JL: Nosocomial influenza B virus infection in the elderly. Ann Intern Med 1982;96:153–158.Google Scholar
9. Catanzaro, A: Nosocomial TB. Am Rev Respir Dis 1984;125:559–562.Google Scholar
10. Burk, JR, Bahar, D, Wolf, FS, et al: Nursery exposure of 528 newborns to a nurse with pulmonary TB. South Med J 1978;71:7–10.Google Scholar
11. Arnow, PM, Chou, T, Weil, D, et al: Nosocomial legionnaires' disease caused by aerosolized tap water from respiratory devices. J Infect Dis 1982;146:460–467.Google Scholar
12. Dondero, TJ Jr Rendtorff, RC, Mallison, GF, et al: An outbreak of legionnaires' disease associated with a contaminated air-conditioning cooling tower. N Engl J Med 1980;302:365–370.Google Scholar
13. Jarvis, WR: Recommended precautions for patients with legionnaires' disease. Infect Control 1982;3:401–402.Google Scholar
14. Sanford, JP, Pierce, AK: Lower respiratory tract infections, in Bennett, JV, Brachman, PS (eds): Hospital Infections, ed 1. Boston, Little, Brown and Co, 1979, pp 255–286.Google Scholar
15. Reinarz, JA, Pierce, AK, Mays, BB, et al: The potential role of inhalation therapy equipment in nosocomial pulmonary infections. J Clin Invest 1965;44:831–839.Google Scholar
16. Cross, AS, Roup, B: Role of respiratory assistance devices in endemic nosocomial pneumonia. Am J Med 1981;70:681–685.Google Scholar
17. Pierce, AK, Sanford, JP, Thomas, GD, et al: Long-term evaluation of decontamination of inhalation-therapy equipment and the occurrence of necrotizing pneumonia. N Engl J Med 1970;282:528–531.Google Scholar
18. Ringrose, RE, McKown, B, Felton, FG, et al: A hospital outbreak of Serratia marcescens associated with ultrasonic nebulizers. Ann Intern Med 1968;69:719–729.Google Scholar
19. Moffet, HL, Allan, D, Williams, T: Survival and dissemination of bacteria in nebulizers and incubators. Am J Dis Child 1967;114:13–20.Google Scholar
20. Simmons, BS, Hooton, TM, Mallison, GF: CDC guideline for hospital environmental control. Am J Infect Control 1983;11:97–115.Google Scholar
21. Simmons, BS, Wong, ES: CDC guideline for prevention of nosocomial pneumonia. Infect Control 1982;3:327–333.Google Scholar
22. Garner, JS, Simmons, BP: CDC guideline for isolation precautions in hospitals. Infect Control 1983;4(Suppl):245–325.Google ScholarPubMed
23. Williams, WW: CDC guideline for infection control in hospital personnel. Infect Control 1983;4(Suppl):326–348.Google Scholar
24. Favero, MS: Chemical disinfection of medical and surgical materials, in Block, SS: Disinfection, Sterilization and Preservation, ed 3. Philadelphia; Lea and Febiger, 1983; pp 469–492.Google Scholar
25. OTC topical antimicrobial products. Federal Register 1978 January 6;43:1211–1249.Google Scholar
26. Ives, KN, Evans, NAP, Thom, BT, et al: Serratia marcescens pseudobacteremia on a special care baby unit (letter). Lancet 1982;2:994–995.Google Scholar
27. Stamm, WE, Colella, JJ, Anderson, RL, et al: Indwelling arterial catheters as a source of nosocomial bacteremia. N Engl J Med 1975;292:1099–1102.Google Scholar
28. Smith, MJ, Hart, CA, Cooke, KW: Gentamicin-resistant Klebsiella oxytoca on a special care baby unit (letter). Lancet 1984;2:586–587.Google Scholar
29. Henderson, DK, Baptiste, RN, Parillo, J, et al: Outbreak of Pseudomonas cepacia infection traced to a contaminated blood gas analyzer, in Abstracts of the Annual Meeting of the American Society for Microbiology. Washington, DC, American Society for Microbiology, 1984;L15.Google Scholar
30. Snydman, DR, Hindman, SH, Wineland, MD, et al: Nosocomial viral hepatitis B. Ann Intern Med 1976;85:573–577.Google Scholar